ICD-10-CM Billable Code

C69.2

Malignant neoplasm of retina

Clinical Classification Guidelines

Excludes Type 1

  • dark area on retina (D49.81)
  • neoplasm of unspecified behavior of retina and choroid (D49.81)
  • retinal freckle (D49.81)

Medical Intelligence & Overview

Malignant neoplasm of the retina, classified under ICD-10 code C69.2, is a serious type of eye cancer that originates in the retina—the light-sensitive tissue lining the back of the eye. Although it is rare, this condition requires prompt medical attention to determine the appropriate treatment and management options. The retina plays a vital role in vision by converting light into neural signals sent to the brain. When a malignant tumor develops in this area, it can threaten both vision and overall health if not diagnosed and treated early.

Causes & Symptoms

Clinical Causes: Genetic mutations that lead to abnormal cell growth in retinal tissue Inheritance of genetic predispositions, such as in familial cancer syndromes Exposure to certain radiation or environmental factors (though rare) Previous history of radiation therapy to the head or eyes

Key Symptoms: Vision changes, such as blurred vision or loss of vision in one eye Flashers or floaters in the visual field A shadow or curtain appearing over part of the visual field Unexplained eye pain or redness (less common) Appearance of a white or yellowish pupil (leukocoria), especially in children Perception of a mass or unusual visual disturbance

Diagnostic & Treatment

Diagnosis Path: Diagnosis of malignant neoplasm of the retina involves several steps:

Treatment Protocols: Treatment approaches vary based on tumor size, location, and extent of spread, and may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C69.2 a billable ICD-10 code?
Yes, C69.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C69.2?
Clinical documentation must specify the nature of Malignant neoplasm of retina and any associated comorbidities for accurate reporting.

Cite this Clinical Reference